Literature DB >> 26273853

Early diagnosis is critical to ensure good outcomes in HIV-infected children: outlining barriers to care.

Ute D Feucht1, Anell Meyer1, Winifred N Thomas1, Brian W C Forsyth1,2, Mariana Kruger3.   

Abstract

HIV-infected children require early initiation of antiretroviral therapy (ART) to ensure good outcomes. The aim was to investigate missed opportunities in childhood HIV diagnosis leading to delayed ART initiation. Baseline data were reviewed of all children aged <15 years referred over a 1-year period for ART initiation to the Kalafong Hospital HIV services in Gauteng, South Africa. Of the 250 children, one-quarter (24.5%) was of school-going age, 34.5% in the preschool group, 18% between 6 and 12 months old and 23% below 6 months of age (median age = 1.5 years [interquartile range 0.5-4.8]). Most children (82%) presented with advanced/severe HIV disease, particularly those aged 6-12 months (95%). Malnutrition was prominent and referrals were mostly from hospital inpatient services (61%). A structured caregiver interview was conducted in a subgroup, with detailed review of medical records and HIV results. The majority (≥89%) of the 65 interviewed caregivers reported good access to routine healthcare, except for postnatal care (26%). Maternal HIV-testing was mostly done during the second and third pregnancy trimesters (69%). Maternal non-disclosure of HIV status was common (63%) and 83% of mothers reported a lack of psychosocial support. Routine infant HIV-testing was not done in 66%, and inadequate reporting on patient-held records (Road-to-Health Cards/Booklets) occurred frequently (74%). Children with symptomatic HIV disease were not investigated at primary healthcare in 53%, and in 68% of families the siblings were not tested. One-third of children (35%) had a previous HIV diagnosis, with 77% of caregivers aware of these prior results, while 50% acknowledged failing to attend ART services despite referral. In conclusion, a clear strategy on paediatric HIV case finding, especially at primary healthcare, is vital. Multiple barriers need to be overcome in the HIV care pathway to reach high uptake of services, of which especially maternal reasons for not attending paediatric ART services need further exploration.

Entities:  

Keywords:  Children; HIV diagnosis; antiretroviral therapy; barriers to care

Mesh:

Substances:

Year:  2015        PMID: 26273853     DOI: 10.1080/09540121.2015.1066748

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  4 in total

1.  Early Antiretroviral Therapy Initiation and Mortality Among Infants Diagnosed With HIV in the First 12 Weeks of Life: Experiences From Kinshasa, DR Congo and Blantyre, Malawi.

Authors:  Anna Sheahan; Lydia Feinstein; Queen Dube; Andrew Edmonds; Chawanangwa Mahebere Chirambo; Emily Smith; Frieda Behets; Robert Heyderman; Annelies Van Rie
Journal:  Pediatr Infect Dis J       Date:  2017-07       Impact factor: 2.129

2.  The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis.

Authors:  Lorna Dunning; Jordan A Francke; Divya Mallampati; Rachel L MacLean; Martina Penazzato; Taige Hou; Landon Myer; Elaine J Abrams; Rochelle P Walensky; Valériane Leroy; Kenneth A Freedberg; Andrea Ciaranello
Journal:  PLoS Med       Date:  2017-11-21       Impact factor: 11.069

3.  Completeness of the Road-to-Health Booklet and Road-to-Health Card: Results of cross-sectional surveillance at a provincial tertiary hospital.

Authors:  Harishia Naidoo; Theunis Avenant; Ameena Goga
Journal:  South Afr J HIV Med       Date:  2018-04-10       Impact factor: 2.744

4.  The impact of viraemia on inflammatory biomarkers and CD4+ cell subpopulations in HIV-infected children in sub-Saharan Africa.

Authors:  Andrew J Prendergast; Alexander J Szubert; Godfrey Pimundu; Chipo Berejena; Pietro Pala; Annie Shonhai; Patricia Hunter; Francesca I F Arrigoni; Victor Musiime; Mutsa Bwakura-Dangarembizi; Philippa Musoke; Hannah Poulsom; Macklyn Kihembo; Paula Munderi; Diana M Gibb; Moira J Spyer; A Sarah Walker; Nigel Klein
Journal:  AIDS       Date:  2021-08-01       Impact factor: 4.177

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.